A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide

Linda Rhodes Biography and Net Worth

Director of Zoetis

Dr. Linda Rhodes has served as a member of our board since August 2017. Dr. Rhodes most recently served as the Chief Scientific Officer of Aratana Therapeutics, a publicly traded animal health company, from 2012 to 2016, and she had also served as Chief Executive Officer and Board member of Aratana from 2011 to 2012. Dr. Rhodes has extensive experience as a research scientist, academic, veterinary practitioner and business leader, spanning nearly 30 years across the animal health industry. She is a founder of AlcheraBio, LLC, a veterinary contract research organization, and held research positions with Merial, Merck and Company, and Sterling-Winthrop Drug Company. She also held several teaching positions and worked as a bovine veterinarian in private practice for many years. Dr. Rhodes formerly served as a member of the Board of Directors of ImmuCell Corporation. She is currently an adjunct faculty member of the Graduate Program in Endocrinology and Animal Biosciences at Rutgers University, New Brunswick, NJ. She serves on the Scientific Advisory Board of the Found Animals Foundation and on the Board of Directors of the Alliance for Contraception in Cats and Dogs.

Dr. Rhodes earned her Ph.D. in Physiology from Cornell University and her V.M.D. from the University of Pennsylvania.

What is Linda Rhodes' net worth?: The estimated net worth of Linda Rhodes is at least $225,279.28 as of September 4th, 2020. Ms. Rhodes owns 1,468 shares of Zoetis stock worth more than $225,279 as of April 18th. This net worth approximation does not reflect any other investments that Ms. Rhodes may own. Learn More about Linda Rhodes' net worth.
How do I contact Linda Rhodes?: The corporate mailing address for Ms. Rhodes and other Zoetis executives is 10 Sylvan Way, Parsippany NJ, 07054. Zoetis can also be reached via phone at (973) 822-7000 and via email at [email protected]. Learn More on Linda Rhodes' contact information.
Has Linda Rhodes been buying or selling shares of Zoetis?: Linda Rhodes has not been actively trading shares of Zoetis during the past quarter. Most recently, Linda Rhodes sold 1,087 shares of the business's stock in a transaction on Friday, September 4th. The shares were sold at an average price of $159.16, for a transaction totalling $173,006.92. Following the completion of the sale, the director now directly owns 1,468 shares of the company's stock, valued at $233,646.88. Learn More on Linda Rhodes' trading history.
Who are Zoetis' active insiders?: Zoetis' insider roster includes Juan Alaix (Director), Heidi Chen (EVP), Glenn David (EVP), Andrew Fenton (EVP), Wetteny Joseph (Exec. VP & CFO ), Robert Kelly (EVP), Catherine Knupp (EVP), Roxanne Lagano (EVP), Clinton Lewis, Jr. (EVP), Gregory Norden (Director), Kristin Peck (CEO), Robert Polzer (EVP), Willie Reed (Director), Linda Rhodes (Director), Robert Scully (Director), and Roman Trawicki (EVP). Learn More on Zoetis' active insiders.
Are insiders buying or selling shares of Zoetis?: In the last twelve months, insiders at the sold shares 13 times. They sold a total of 49,823 shares worth more than $8,985,800.22. The most recent insider tranaction occured on March, 18th when EVP Roxanne Lagano sold 923 shares worth more than $159,983.59. Insiders at Zoetis own 0.1% of the company. Learn More about insider trades at Zoetis.
Information on this page was last updated on 3/18/2024.

Linda Rhodes Insider Trading History at Zoetis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/4/2020	Sell	1,087	$159.16	$173,006.92	1,468

Linda Rhodes Buying and Selling Activity at Zoetis

Zoetis Company Overview

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Today's Range

Now: $153.46

$151.17

$153.67

50 Day Range

MA: $177.35

$149.81

$199.94

2 Week Range

Now: $153.46

$148.48

$201.92

Volume

1,551,963 shs

Average Volume

2,943,113 shs

Market Capitalization

$70.19 billion

P/E Ratio

30.27

Dividend Yield

1.13%

Beta

0.85

[Urgent!] Generational Wealth Gameplan

From Crypto 101 Media | Ad